Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
Clinical trial NCT05110170 · COMPLETED
Trial details
- NCT number
- NCT05110170
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-04-05
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.